agilon health (NYSE:AGL) Given New $4.00 Price Target at Deutsche Bank Aktiengesellschaft

agilon health (NYSE:AGL) had its target price trimmed by Deutsche Bank Aktiengesellschaft from $5.00 to $4.00 in a research report released on Friday, Benzinga reports. The firm currently has a hold rating on the stock.

AGL has been the subject of a number of other research reports. Robert W. Baird initiated coverage on agilon health in a research report on Thursday, May 30th. They set a neutral rating and a $6.00 price target for the company. Citigroup initiated coverage on agilon health in a research report on Monday, April 22nd. They set a neutral rating and a $6.00 price target for the company. Evercore ISI boosted their price target on agilon health from $5.50 to $7.00 and gave the stock an in-line rating in a research report on Tuesday, July 9th. Truist Financial boosted their price target on agilon health from $6.40 to $6.50 and gave the stock a hold rating in a research report on Friday, May 24th. Finally, Stifel Nicolaus cut their price objective on agilon health from $8.00 to $7.00 and set a hold rating for the company in a report on Wednesday, May 1st. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of Hold and an average target price of $8.57.

agilon health Stock Performance

AGL traded down $0.08 during trading on Friday, reaching $5.52. 5,045,390 shares of the company were exchanged, compared to its average volume of 5,138,099. The stock has a market cap of $2.27 billion, a P/E ratio of -7.89 and a beta of 0.60. The firm has a 50 day moving average of $6.51 and a 200 day moving average of $5.99. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.04. agilon health has a 52 week low of $4.41 and a 52 week high of $20.37.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting analysts’ consensus estimates of ($0.07). agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The firm had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the business earned ($0.04) EPS. The firm’s revenue was up 38.7% on a year-over-year basis. On average, sell-side analysts forecast that agilon health will post -0.34 EPS for the current fiscal year.

Institutional Trading of agilon health

Hedge funds have recently modified their holdings of the business. Quest Partners LLC acquired a new position in shares of agilon health in the fourth quarter worth $45,000. Neo Ivy Capital Management purchased a new stake in shares of agilon health during the 4th quarter worth about $47,000. J.Safra Asset Management Corp lifted its holdings in shares of agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in shares of agilon health by 31.5% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 8,969 shares of the company’s stock valued at $113,000 after buying an additional 2,149 shares during the last quarter. Finally, CWM LLC increased its holdings in agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.